ID   NKI-2
AC   CVCL_LI41
SY   NKI2; Nederlands Kanker Instituut-2
DR   Wikidata; Q54930670
RX   PubMed=1079770;
RX   PubMed=1104492;
RX   PubMed=4549213;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 3
//
RX   PubMed=1079770; DOI=10.1016/0014-2964(75)90007-9;
RA   Vanwijck R., Bouillenne C., Malek-Mansour S.;
RT   "Potentiation and arming of lymphocyte mediated immunity by sera from
RT   melanoma patients.";
RL   Eur. J. Cancer 11:267-276(1975).
//
RX   PubMed=1104492; DOI=10.1002/ijc.2910160612;
RA   Cornain S., de Vries J.E., Collard J., Vennegoor C., van Wingerden I.,
RA   Rumke P.;
RT   "Antibodies and antigen expression in human melanoma detected by the
RT   immune adherence test.";
RL   Int. J. Cancer 16:981-997(1975).
//
RX   PubMed=4549213; DOI=10.1002/ijc.2910140402;
RA   de Vries J.E., Cornain S., Rumke P.;
RT   "Cytotoxity of non-T versus T-lymphocytes from melanoma patients and
RT   healthy donors on short- and long-term cultured melanoma cells.";
RL   Int. J. Cancer 14:427-434(1974).
//